Literature DB >> 7056282

Distribution of lithium elimination rates in a selected population of psychiatric patients.

D P Thornhill, S P Field.   

Abstract

Chronic treatment with conventional lithium carbonate was interrupted in a selected group of 40 psychiatric patients of mixed sex and race. All patients had normal renal function. Serum samples were taken 12, 24, 36 and 48 h after the last dose and lithium was assayed by atomic absorption spectrophotometry. Decay rates calculated for the 12-24h and 36-48 h periods yielded different values. This was ascribed to the presence of an incomplete redistribution phase during the earlier period. The distribution of elimination rates determined during the later period gave a more symmetrical spread and approximated a normal distribution. The mode, median, mean and standard deviation of the lithium elimination half-lives were 12.5, 14, 18.2 and 7.3h and 22.5, 24.5, 29.8 and 10.1h for the two periods, respectively. The results contrast sharply with another report of the distribution spread of elimination half-lives in a much larger sample. The current values have implications for dosage prediction, serum level monitoring and dosage formulation, especially sustained-release preparations. The evidence was against the possibility that some individuals "retain' lithium.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7056282     DOI: 10.1007/bf00637625

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

Review 1.  Serum level monitoring and clinical pharmacokinetics of lithium.

Authors:  A Amdisen
Journal:  Clin Pharmacokinet       Date:  1977 Mar-Apr       Impact factor: 6.447

2.  Lithium retention and response.

Authors:  M Serry
Journal:  Lancet       Date:  1969-06-21       Impact factor: 79.321

3.  Estimation of pharmacokinetic parameters of lithium from saliva and urine.

Authors:  U Groth; W Prellwitz; E Jähnchen
Journal:  Clin Pharmacol Ther       Date:  1974-09       Impact factor: 6.875

4.  Serum lithium estimations.

Authors:  A Amdisen
Journal:  Br Med J       Date:  1973-04-28

5.  The measurement of lithium in biologic samples by atomic absorption spectrophotometry.

Authors:  B R Little; S R Platman; R R Fieve
Journal:  Clin Chem       Date:  1968-12       Impact factor: 8.327

6.  Diagnostic criteria for use in psychiatric research.

Authors:  J P Feighner; E Robins; S B Guze; R A Woodruff; G Winokur; R Munoz
Journal:  Arch Gen Psychiatry       Date:  1972-01

7.  The Lithium Excretion Test: II. Practical and Biochemical Aspects.

Authors:  M Serry; S Andrews
Journal:  Aust N Z J Psychiatry       Date:  1969       Impact factor: 5.744

8.  The lithium excretion test: I. Clinical application and interpretation.

Authors:  M Serry
Journal:  Aust N Z J Psychiatry       Date:  1969       Impact factor: 5.744

9.  Pharmacokinetics of lithium: elimination half-time, renal clearance and apparent volume of distribution in schizophrenia.

Authors:  R W Mason; E G McQueen; P J Keary; N M James
Journal:  Clin Pharmacokinet       Date:  1978 May-Jun       Impact factor: 6.447

10.  Pharmacokinetics of ordinary and sustained-release lithium carbonate in manic patients after acute dosage.

Authors:  D P Thornhill
Journal:  Eur J Clin Pharmacol       Date:  1978-12-01       Impact factor: 2.953

View more
  1 in total

1.  A kinetic evaluation of 14CO2 in expired air after 14C-methacetin administration in rats, used for the in vivo study of the metabolism of drugs.

Authors:  D P Thornhill; C Steffen; K J Netter
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Apr-Jun       Impact factor: 2.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.